CIEL PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CIEL PHARMA
Largest movements
- Receivables within one year -€526,960
down €526,960 (-82.9%), from €635,520 to €108,560
of which Other amounts receivable: -€405,955
- Receivables after one year +€396,858
new in 2024: €396,858
- Tangible fixed assets -€18,360
down €18,360 (-4.1%), from €448,646 to €430,286
of which Land and buildings: -€13,389
- Other debts -€202,954
down €202,954 (-28.6%), from €708,721 to €505,767
- Debts after one year -€62,882
down €62,882 (-8.3%), from €759,848 to €696,966
- Trade debts +€49,574
up €49,574 (+166%), from €29,850 to €79,424
- Tax, wage and social debts +€49,491
up €49,491 (+97.0%), from €50,998 to €100,489
of which Taxes: +€51,308
- Staff costs +€42,420
up €42,420 (+736%), from €5,766 to €48,186
- Gross operating margin +€19,581
up €19,581 (+24.8%), from €78,937 to €98,518
- Taxes -€16,314
no longer reported in 2024 (was €16,314)
- Financial income -€8,599
down €8,599 (-60.2%), from €14,295 to €5,696
- Other operating charges -€4,312
down €4,312 (-99.2%), from €4,349 to €36
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,768,759 | €1,617,505 | -€151,254 | -8.6% |
| Fixed assets | 21/28 | €1,133,192 | €1,112,087 | -€21,105 | -1.9% |
| Tangible fixed assets | 22/27 | €448,646 | €430,286 | -€18,360 | -4.1% |
| Land and buildings | 22 | €438,872 | €425,483 | -€13,389 | -3.1% |
| Plant, machinery and equipment | 23 | €8,599 | €4,803 | -€3,796 | -44.1% |
| Furniture and vehicles | 24 | €1,176 | - | -€1,176 | |
| Financial fixed assets | 28 | €684,546 | €681,801 | -€2,745 | -0.4% |
| Current assets | 29/58 | €635,567 | €505,417 | -€130,150 | -20.5% |
| Amounts receivable after more than one year | 29 | - | €396,858 | +€396,858 | |
| Other amounts receivable | 291 | - | €396,858 | +€396,858 | |
| Amounts receivable within one year | 40/41 | €635,520 | €108,560 | -€526,960 | -82.9% |
| Trade receivables | 40 | €121,006 | - | -€121,006 | |
| Other amounts receivable | 41 | €514,514 | €108,560 | -€405,955 | -78.9% |
| Cash at bank and in hand | 54/58 | €0 | - | = | |
| Deferred charges and accrued income | 490/1 | €47 | - | -€47 | |
| Total equity and liabilities | 10/49 | €1,768,759 | €1,617,505 | -€151,254 | -8.6% |
| Equity | 10/15 | €151,035 | €166,036 | +€15,001 | +9.9% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | €144,835 | €159,836 | +€15,001 | +10.4% |
| Amounts payable | 17/49 | €1,617,724 | €1,451,469 | -€166,256 | -10.3% |
| Amounts payable after more than one year | 17 | €759,848 | €696,966 | -€62,882 | -8.3% |
| Financial debts | 170/4 | €759,848 | €696,966 | -€62,882 | -8.3% |
| Amounts payable within one year | 42/48 | €857,877 | €754,503 | -€103,374 | -12.0% |
| Current portion of amounts payable after more than one year | 42 | €63,563 | €68,823 | +€5,260 | +8.3% |
| Financial debts | 43 | €4,745 | - | -€4,745 | |
| Credit institutions | 430/8 | €4,745 | - | -€4,745 | |
| Trade debts | 44 | €29,850 | €79,424 | +€49,574 | +166% |
| Suppliers | 440/4 | €29,850 | €79,424 | +€49,574 | +166% |
| Taxes, remuneration and social security | 45 | €50,998 | €100,489 | +€49,491 | +97.0% |
| Taxes | 450/3 | €47,774 | €99,082 | +€51,308 | +107% |
| Remuneration and social security | 454/9 | €3,224 | €1,406 | -€1,817 | -56.4% |
| Other amounts payable | 47/48 | €708,721 | €505,767 | -€202,954 | -28.6% |
| Remuneration, social security and pensions | 62 | €5,766 | €48,186 | +€42,420 | +736% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €18,361 | €18,360 | -€1 | 0.0% |
| Other operating charges | 640/8 | €4,349 | €36 | -€4,312 | -99.2% |
| Gross operating margin | 9900 | €78,937 | €98,518 | +€19,581 | +24.8% |
| Operating profit (loss) | 9901 | €50,460 | €31,936 | -€18,525 | -36.7% |
| Financial income | 75/76B | €14,295 | €5,696 | -€8,599 | -60.2% |
| Recurring financial income | 75 | €14,295 | €5,696 | -€8,599 | -60.2% |
| Financial charges | 65/66B | €19,879 | €22,630 | +€2,751 | +13.8% |
| Recurring financial charges | 65 | €19,879 | €22,630 | +€2,751 | +13.8% |
| Profit (loss) for the period before taxes | 9903 | €44,876 | €15,001 | -€29,874 | -66.6% |
| Income taxes | 67/77 | €16,314 | - | -€16,314 | |
| Profit (loss) for the period | 9904 | €28,561 | €15,001 | -€13,560 | -47.5% |
| Profit (loss) for the period to be appropriated | 9905 | €28,561 | €15,001 | -€13,560 | -47.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.